Pyrazolopyrimidines as P13K lipid kinase inhibitors

Details for Australian Patent Application No. 2007302263 (hide)

Owner Novartis AG

Inventors Capraro, Hans-Georg; Furet, Pascal; Imbach, Patricia; Stauffer, Frederic

Agent Davies Collison Cave

Pub. Number AU-A-2007302263

PCT Pub. Number WO2008/037477

Priority 06121476.3 29.09.06 EP

Filing date 27 September 2007

Wipo publication date 3 April 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

19 March 2009 PCT application entered the National Phase

  PCT publication WO2008/037477 Priority application(s): WO2008/037477

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007302270-Formulations comprising cyclic compounds

2007302262-Oxadiazole derivatives with antiinflammatory and immunosuppressive properties